72 related articles for article (PubMed ID: 1364278)
21. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
22. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial.
Fallone CA; Loo V; Joseph L; Barkun J; Kostyk R; Barkun AN
Clin Invest Med; 1999 Oct; 22(5):185-94. PubMed ID: 10579057
[TBL] [Abstract][Full Text] [Related]
23. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"].
Gorshkov VA
Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232
[No Abstract] [Full Text] [Related]
24. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic factors of efficacy of eradication therapy in patients with duodenal ulcer].
Kozlova IV; Eliseev IuIu; Pakhomova AL; Khan SA
Klin Med (Mosk); 2005; 83(7):52-5. PubMed ID: 16117427
[TBL] [Abstract][Full Text] [Related]
26. Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
Gabryelewicz A; Laszewicz W; Dzieniszewski J; Ciok J; Marlicz K; Bielecki D; Popiela T; Legutko J; Knapik Z; Poniewierka E
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():93-105. PubMed ID: 9440060
[TBL] [Abstract][Full Text] [Related]
27. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
[TBL] [Abstract][Full Text] [Related]
28. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
[TBL] [Abstract][Full Text] [Related]
29. Gastric bicarbonate secretion in high-relapsing, smoking duodenal ulcer patients.
Dal Santo P; Vianello F; Germana B; Del Bianco T; Laino G; Grassi SA; Plebani M; Dotto P; Battaglia G; Di Mario F
Hepatogastroenterology; 1993 Apr; 40(2):120-2. PubMed ID: 8099560
[TBL] [Abstract][Full Text] [Related]
30. Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients.
Plein K; Madisch A; Stolte M; Hotz J
Z Gastroenterol; 2001 Jul; 39(7):503-10. PubMed ID: 11505330
[TBL] [Abstract][Full Text] [Related]
31. Duodenal Helicobacter pylori associated duodenal ulcer depend on gastric Helicobacter pylori status.
Vilaichone RK; Mahachai V; Tumwasorn S; Nunthapisud P; Wisedopas N; Kullavanijaya P
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S97-102. PubMed ID: 12188459
[TBL] [Abstract][Full Text] [Related]
32. [Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
García-Romero E; del Val A; Garrigues V; Cuquerella J; Higón MD; Barrachina M; Pons V; Bixquert M; Ponce J
Gastroenterol Hepatol; 1999 Jan; 22(1):1-6. PubMed ID: 10089703
[TBL] [Abstract][Full Text] [Related]
33. [Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
Mansurova FKh; Kadyrov DM; Odinaev RI; Ishankulova DM
Klin Med (Mosk); 2000; 78(6):53-6. PubMed ID: 10900873
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic management of duodenal ulcer except in emergency: eradication of Helicobacter pylori].
Lamouliatte H
Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S58-S63. PubMed ID: 8734372
[No Abstract] [Full Text] [Related]
35. High IgE serum levels and "peptic" ulcers: clinical and functional approach.
De Lazzari F; Mancin O; Plebani M; Venturi C; Battaglia G; Vianello F; Galliani EA; Di Mario F; Naccarato R
Ital J Gastroenterol; 1994; 26(1):7-11. PubMed ID: 7912969
[TBL] [Abstract][Full Text] [Related]
36. Peptic ulcer disease in the elderly.
Cryer B; Feldman M
Semin Gastrointest Dis; 1994 Oct; 5(4):166-78. PubMed ID: 7834250
[No Abstract] [Full Text] [Related]
37. [The effect of "triple therapy" on the eradicating of H. pylori and the healing of a duodenal ulcer. The initial study and 6 months later].
Gisbert JP; Boixeda D; de Rafael L; Martín de Argila C; Bermejo F; García Plaza A
Rev Esp Enferm Dig; 1995 Mar; 87(3):193-8. PubMed ID: 7742047
[TBL] [Abstract][Full Text] [Related]
38. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
Lanas A; Remacha B; Sáinz R; Hirschowitz BI
Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
[TBL] [Abstract][Full Text] [Related]
39. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
40. [Changes in the natural history of peptic ulcer after Helicobacter pylori eradication. Randomized, double-blind, placebo controlled trial. Follow-up of 44 months].
Piñero R; Ramon Poleo J; Urrestarazo M; Serrano N; Olavarría R
G E N; 1995; 49(1):50-4. PubMed ID: 8566673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
